Pulmatrix, Inc. (NASDAQ:PULM), a pharmaceutical company currently valued at $27.4 million, announced on Monday that its board of directors approved an amendment to the company's bylaws, specifically ...
Beyond compliance: Can stock exchange and accounting bodies drive corporate environmental reporting?
As Sri Lanka navigates economic recovery and a shifting global sustainability landscape, corporate environmental disclosures ...
Definitions of accounting deployed today are observably narrow, outdated, and increasingly unsuitable for realizing the full ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback